Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

Market Cap	3.10B +11.2%
Revenue (ttm)	1.11B +9.8%
Net Income	86.79M -27.9%
EPS	0.83 -27.8%
Shares Out	105.91M
PE Ratio	35.20
Forward PE	n/a
Dividend	0.20 (0.66%)
Ex-Dividend Date	n/a

Volume	2,317,500
Average Volume	2,578,828
Open	30.53
Previous Close	30.19
Day's Range	29.20 - 30.53
52-Week Range	26.70 - 42.88
Beta	-0.20
RSI	34.61
Earnings Date	Apr 28, 2026

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd was founded in 1997 and is based in Xi'an, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 933
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002864

Financial Performance

In 2025, SHE:002864's revenue was 1.14 billion, an increase of 17.15% compared to the previous year's 973.86 million. Earnings were 96.28 million, a decrease of -19.95%.